Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 16, 2020 - Issue 2
227
Views
6
CrossRef citations to date
0
Altmetric
Articles

Predictive Outcome Validity of General Health Questionnaire (GHQ-28) in Substance Abuse Patients Treated in Therapeutic Communities

, PhDORCID Icon & , MDORCID Icon

References

  • American Psychiatric Association [APA]. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychological Association Press.
  • Arenas, F., del Valle, M., Lopez, R., Martin, J., & Tirado, P. (2003). Programa de intervención. Comunidad terapéutica en Andalucía [Intervention program. Therapeutic community in Andalusia]. Sevilla: Consejería de Asuntos Sociales. Comisionado para las Drogodependencias. Junta de Andalucía.
  • Condelli, W. S. (1994). Domains of variables for understanding and improving retention in therapeutic communities. International Journal of the Addictions, 29, 593–607. doi:10.3109/10826089409047402
  • Condelli, W. S., & De Leon, G. (1993). Fixed and dynamic predictors of client retention in therapeutic communities. Journal of Substance Abuse Treatment, 10, 11–16. doi:10.1016/0740-5472(93)90093-H
  • Condelli, W.S., & Hubbard, R. L. (1994) Relationship between time spent in treatment and client outcomes from therapeutic communities. Journal of Substance Abuse Treatment, 11, 25–33. doi:10.1016/0740-5472(94)90061-2
  • Darke, S., Campbell, G., & Popple, G. (2012). Retention, early dropout and treatment completion among therapeutic community admissions. Drug and Alcohol Review, 31, 64–71. doi:10.1111/j.1465-3362.2011.00298.x
  • Darke, S., Wodak, A., Hall, W., Heather, N., & Ward, J. (1992). Prevalence and predictors of psychopathology among opioid users. British Journal of Addiction, 87(5), 771–776. doi:10.1111/j.1360-0443.1992.tb02723.x
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]. (2017). European drugs report: Trends and developments. Luxembourg: Publication Office of the European Union.
  • Fernández-Hermida, J. R., Secades-Villa, R., Fernández-Ludeña, J. J., & Marina-González, P. A. (2002). Effectiveness of a therapeutic community treatment in Spain: A long-term follow-up study. European Addiction Research, 8, 22–29. doi:10.1159/000049484
  • Goldberg, D. P., & Hillier, V. F. (1979). A scaled version of the General Health Questionnaire. Psychological Medicine, 9, 139–149. doi:10.1017/S0033291700021644
  • González-Saiz, F., Ruz Franzi, I., & Carulla, L. S. (1998). Estudio de detección de probables casos psiquiátricos en una muestra de pacientes dependientes de opiáceos en tratamiento ambulatorio [Study of detection of probable psychiatric cases in a sample of opiate-dependent patients in outpatient treatment]. Revista Española de Drogodependencias, 23(2), 161–168.
  • González-Saiz, F., Vergara-Moragues, E., Verdejo-García, A., Fernández-Calderón, F., & Lozano-Rojas, O. (2014). Impact of psychiatric comorbidity on the in-treatment outcomes of cocaine-dependent patients on therapeutic community. Substance Abuse, 35(2), 133–140. doi:10.1080/08897077.2013.812544
  • Gullo, M. J., Matveeva, M., Feeney, G. F., Young, R. M., & Connor, J. P. (2017). Social cognitive predictors of treatment outcome in cannabis dependence. Drug and Alcohol Dependence, 170, 74–81. doi:10.1016/j.drugalcdep.2016.10.030
  • Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. The American Journal of Psychiatry, 163(4), 689–696. doi:10.1176/ajp.2006.163.4.689
  • Herbeck, D. M., Hser, Y. I., Lu, A. T., Stark, M. E., & Paredes, A. (2006). A 12-year follow-up study of psychiatric symptomatology among cocaine-dependent men. Addictive Behaviors, 31(11), 1974–1987. doi:10.1016/j.addbeh.2006.01.013
  • Hser, Y. (2007). Predicting long-term stable recovery from heroin addiction: Findings from a 33-year follow-up. Journal of Addictive Diseases, 26, 51–60. doi:10.1300/J069v26n01_07
  • Kessler, R., Ustun, T. (2004). The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 13, 93–121. doi:10.1002/mpr.168
  • Langås, A. M., Malt, U. F., & Opjordsmoen, S. (2012). In-depth study of personality disorders in first-admission patients with substance use disorder. BMC Psychiatry, 12, 180. doi:10.1186/1471-244X-12-180
  • Lobo, A., Pérez-Echeverría, M. J., & Artal, J. (1986). Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychological Medicine, 16, 135–140. doi:10.1017/S0033291700002579
  • Loree, A. M., Yeh H. H., Satre, D. D., Kline-Simon, A. H., Jo H Yarborough, B., Haller, I. V., Campbell, C. I.,… Ahmendani, B. K. (2019). Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems. Substance Abuse, 25(1–7). doi:10.1080/08897077.2018.1545727
  • Lozano, O. M., Rojas, A. J. & Fernández-Calderón, F. (2017). Psychiatric comorbidity and severity of dependence on substance users: How it impacts on their health-related quality of life? Journal of Mental Health, 26(2), 119–126. doi:10.1080/09638237.2016.1177771
  • Malakouti, S. K., Fatollahi, P., Mirabzadeh, A., & Zandi, T. (2006). Reliability, validity and factor structure of the GHQ-28 used among elderly Iranians. International Psychogeriatrics, 19, 623–634. doi:10.1017/S1041610206004522
  • Malivert, M., Fatséas, M., Denis, C., Langlois, E., & Auriacombe, M. (2012). Effectiveness of therapeutic communities: A systematic review. European Addiction Research, 18, 1–11. doi:10.1159/000331007
  • Maremmani, A. G. I., Pani, P. P., Trogu, E., Vigna-Taglianti, F., Mathis, F., Diecidue, R.,… Maremmani, I. (2016). The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment. Annals of General Psychiatry, 15, 29. doi:10.1186/s12991-016-0119-x
  • Martín-Santos, R., Fonseca, F., Domingo-Salvany, A., Ginés, J. M., Imaz, M. L., Navines, R., … Torrens, M. (2006). Dual diagnosis in the psychiatric emergency room in Spain. The European Journal of Psychiatry, 20(3), 147–156. doi:10.4321/S0213-61632006000300002
  • McLellan, A.T. (2002). Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction, 97, 249–252. doi:10.1046/j.1360-0443.2002.00127.x
  • Mulder, R. T., Frampton, C. M., Peka, H., Hampton, G., & Marsters, T. (2009). Predictors of 3-month retention in a drug treatment therapeutic community. Drug and Alcohol Review, 28, 366–371. doi:10.1111/j.1465-3362.2009.00050.x
  • Papinczak, Z. E., Connor, J. P., Feenery, G. F., Young, R. M., & Gullo, M. J. (2017). Treatment seeking in cannabis dependence: The role of social cognition. Drug and Alcohol Dependence, 170, 142–146. doi:10.1016/j.drugalcdep.2016.11.005
  • Pereiro, C., Pino, C., Flórez, G., Arrojo, M., Becoña, E., & COPSIAD Group. (2013). Psychiatric comorbidity in patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study. PLoS ONE, 8(6), e66451. doi:10.1371/journal.pone.0066451
  • Pérez-Moreno, P., Lozano Rojas, O., & Rojas Tejada, A. (2010). Propiedades psicométricas del GHQ-28 en pacientes con dependencia a opiáceos [Psychometric properties of the GHQ-28 in patients with opiate dependence]. Adicciones, 22(1), 65–72. doi:10.20882/adicciones.216
  • Rodríguez-Cintas, L., Daigre, C., Braquehais, M.D, Palma-Alvarez, R.F., Grau-López, L., Ros-Cucurull, E., … Roncero, C. (2018). Factors associated with lifetime suicidal ideation and suicide attempts in outpatients with substance use disorders. Psychiatry Research, 262, 440–445. doi:10.1016/j.psychres.2017.09.021
  • Roncero, C., de Miguel, A., Fumero, A., Abad, A. C., Martín, R., Bethencourt, J.M., … Daigre, C. (2018). Anxiety and depression in drug-dependent patients with Cluster C personality disorders. Frontiers of Psychiatry, 8(9), 19. doi:10.3389/fpsyt.2018.00019
  • Samuel, D. B., LaPaglia, D. M., Maccarelli, L. M., Moore, B. A., & Ball, S. A. (2011). Personality disorders and retention in a therapeutic community for substance dependence. The American Journal on Addictions, 20(6), 555–562. doi:10.1111/j.1521-0391.2011.00174.x
  • Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G. (1998). The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview. Journal of Clinical Psychiatry, 59(S20), 22–23.
  • Simpson, D. D. (2001). Modeling treatment process and outcomes. Addiction, 96(2), 207–211. doi:10.1046/j.1360-0443.2001.9622073.x
  • Simpson, D. D. (2004). A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment, 27, 99–121. doi:10.1016/j.jsat.2004.06.001
  • Staiger, P. K., Kyrios, M., Williams, J. S., Kambouropoulos, N., Howard, A., & Gruenert, S. (2014). Improving the retention rate for residential treatment of substance abuse by sequential intervention for social anxiety. BMC Psychiatry, 14, 43. doi:10.1186/1471-244X-14-43
  • Swift, W., Williams, G., Neill, O., & Grenyer, B. (1990). The prevalence of minor psychopathology in opioid users seeking treatment. British Journal of Addiction, 85(5), 629–634. doi:10.1111/j.1360-0443.1990.tb03523.x
  • Tamburin, S., Federico, A., Faccini, M., Casari, R., Morbioli, L., Sartore, V., … Lugoboni, F. (2017). Determinants of quality of life in high-dose benzodiazepine misusers. International Journal of Environmental Research and Public Health, 14(1), 38. doi:10.3390/ijerph14010038
  • Trujols, J., Garijo, I., Siño, N., del Pozo, J., Portella, M. J. & Pérez de los Cobos, J. (2012). Patient satisfaction with methadone maintenance treatment: The relevance of participation in treatment and social functioning. Drug and Alcohol Dependence, 123, 41–47. doi:10.1016/j.drugalcdep.2011.10.014
  • United Nations Office on Drugs and Crime [UNODC]. (2017). World drug report: Executive summary, I-XIII. New York, NY: United Nations Publication, Sales N°. E.15.XI.6. Retrieved from https://data.unodc.org/#state:1
  • Vergara-Moragues, E., González-Saiz, F., Lozano-Rojas, O., Betanzos-Espinosa, P., Fernández-Calderón, F., Bilbao-Acedos, I., … Verdejo-García, A. (2012). Psychiatric comorbidity in cocaine users treated in therapeutic community: Substance-induced versus independent disorders. Psychiatry Research, 200(2–3), 734–741. doi:10.1016/j.psychres.2012.07.043
  • Vergara-Moragues, E., González-Saiz, F, Lozano-Rojas, O., & Verdejo-García, A. (2013). Psychiatric profile of three-month retention in cocaine-dependent patients treated in a therapeutic community. Journal of Studies on Alcohol and Drugs, 74(3), 452–459. doi:10.15288/jsad.2013.74.452
  • Werneke, U., Goldberg, D. P., Yalcin, I., & Ustün, B. T. (2000). The stability of the factor structure of the General Health Questionnaire. Psychological Medicine, 30, 823–829. doi:10.1017/S0033291799002287
  • World Health Organization [WHO]. (2016). The ICD-11 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines (11th revision). Geneva: World Health Organization.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.